Abstract
To evaluate the effectiveness of hepatic arterial infusion chemotherapy (HAIC) for advanced hepatocellular carcinoma (HCC) resistant to transarterial chemoembolization (TACE). This study was conducted on 42 patients who received HAIC for advanced HCC between 2001 and 2010 at our hospital. 5-fluorouracil (5-FU) was administered continuously for 24 h from day 1 to day 5 every 2-4 wk via an injection reservoir. Intra-arterial cisplatin or subcutaneous interferon was administered in combination with the 5-FU. The patients enrolled in this retrospective study were divided into two groups according to whether or not they fulfilled the criteria for resistance to TACE proposed by the Japan Society of Hepatology in 2010 (written in Japanese); one group of patients who did not fulfill the criteria for TACE resistance (group A, n = 23), and another group who fulfilled the criteria for TACE resistance (group B, n = 19). We compared the outcomes in terms of the response and survival rates between the two groups. Both the response rate and tumor suppression rate following HAIC were significantly superior in group A than in group B (response rate: 48% vs 16%, P = 0.028, tumor suppression rate: 87% vs 53%, P = 0.014). Furthermore, both the pro...Continue Reading
References
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Feb 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J Bruix
Oct 31, 1997·Lancet·S D Taylor-RobinsonH C Thomas
Oct 24, 1998·Annals of Internal Medicine·E MorM Schwartz
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Mar 11, 1999·The New England Journal of Medicine·H B El-Serag, A C Mason
Mar 1, 2002·Oncology·Shuichiro ShiinaMasao Omata
Mar 20, 2002·Cancer·Masato SakonMorito Monden
Sep 5, 2002·Cancer·Eiji AndoMichio Sata
May 9, 2003·Surgical Oncology Clinics of North America·Kamran Ahrar, Sanjay Gupta
May 22, 2003·Radiology·Riccardo A LencioniCarlo Bartolozzi
Dec 12, 2003·Lancet·Josep M LlovetJordi Bruix
Mar 28, 2006·Cancer·Shuntaro ObiMasao Omata
Aug 8, 2006·Gastroenterology·Kenichi TakayasuUNKNOWN Liver Cancer Study Group of Japan
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Oct 18, 2007·Cancer·Hiroaki NaganoMorito Monden
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Feb 20, 2009·Oncology·Masatoshi Kudo
Dec 20, 2008·The Lancet Oncology·Ann-Lii ChengZhongzhen Guan
Jul 17, 2010·Oncology·Masatoshi Kudo, Kazuomi Ueshima
Citations
Oct 30, 2012·Cytotechnology·Ngoc Bich VuPhuc Van Pham
Aug 8, 2013·World Journal of Gastroenterology : WJG·Do Seon SongSeung Kew Yoon
Jun 25, 2013·Journal of Gastroenterology·Masafumi IkedaTakuji Okusaka
Sep 10, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kazuto TajiriToshiro Sugiyama
Oct 18, 2013·Clinical and Molecular Hepatology·Myung Jin OhSi Hyung Lee
Jul 21, 2012·PloS One·Fenghua LiuJihui Hao
Dec 9, 2014·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Bohuslav MelicharAntonin Krajina
Apr 13, 2018·Journal of Gastroenterology and Hepatology·Kenichiro KodamaKazuaki Chayama
Dec 18, 2015·Molecular Medicine Reports·Jian HuangShu Zhang
Apr 9, 2015·World Journal of Gastroenterology : WJG·Hyung Joon YimSoon Ho Um